BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 23644977)

  • 1. C-5 hydroxyethyl and hydroxypropyl acyclonucleosides as substrates for thymidine kinase of herpes simplex virus type 1 (HSV-1 TK): syntheses and biological evaluation.
    Meščić A; Krištafor S; Novaković I; Osmanović A; Müller U; Završnik D; Ametamey SM; Scapozza L; Raić-Malić S
    Molecules; 2013 May; 18(5):5104-24. PubMed ID: 23644977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorosubstitution and 7-alkylation as prospective modifications of biologically active 6-aryl derivatives of tricyclic acyclovir and ganciclovir analogues.
    Ostrowski T; Golankiewicz B; De Clercq E; Balzarini J
    Bioorg Med Chem; 2005 Mar; 13(6):2089-96. PubMed ID: 15727862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The A167Y mutation converts the herpes simplex virus type 1 thymidine kinase into a guanosine analogue kinase.
    Balzarini J; Liekens S; Esnouf R; De Clercq E
    Biochemistry; 2002 May; 41(20):6517-24. PubMed ID: 12009916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity of monkey B virus (Cercopithecine herpesvirus 1) to antiviral drugs: role of thymidine kinase in antiviral activities of substrate analogs and acyclonucleosides.
    Focher F; Lossani A; Verri A; Spadari S; Maioli A; Gambino JJ; Wright GE; Eberle R; Black DH; Medveczky P; Medveczky M; Shugar D
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2028-34. PubMed ID: 17438061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new nucleoside analogue with potent activity against mutant sr39 herpes simplex virus-1 (HSV-1) thymidine kinase (TK).
    Sundaram GS; Harpstrite SE; Kao JL; Collins SD; Sharma V
    Org Lett; 2012 Jul; 14(14):3568-71. PubMed ID: 22765027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new acycloguanosine-specific supermutant of herpes simplex virus type 1 thymidine kinase suitable for PET imaging and suicide gene therapy for potential use in patients treated with pyrimidine-based cytotoxic drugs.
    Likar Y; Dobrenkov K; Olszewska M; Vider E; Shenker L; Cai S; Pillarsetty N; Hricak H; Ponomarev V
    J Nucl Med; 2008 May; 49(5):713-20. PubMed ID: 18413388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, 18F-radiolabelling and biological evaluations of C-6 alkylated pyrimidine nucleoside analogues.
    Raić-Malić S; Johayem A; Ametamey SM; Batinac S; De Clercq E; Folkers G; Scapozza L
    Nucleosides Nucleotides Nucleic Acids; 2004; 23(11):1707-21. PubMed ID: 15598073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modifications on the heterocyclic base of ganciclovir, penciclovir, acyclovir - syntheses and antiviral properties.
    Chuchkov K; Chayrov R; Hinkov A; Todorov D; Shishkova K; Stankova IG
    Nucleosides Nucleotides Nucleic Acids; 2020; 39(7):979-990. PubMed ID: 32312162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new N-methyl thymine derivative comprising a dihydroxyisobutenyl unit as ligand for thymidine kinase of herpes simplex virus type 1 (HSV-1 TK).
    Krištafor S; Novaković I; Gazivoda Kraljević T; Kraljević Pavelić S; Lučin P; Westermaier Y; Pernot L; Scapozza L; Ametamey SM; Raić-Malić S
    Bioorg Med Chem Lett; 2011 Oct; 21(20):6161-5. PubMed ID: 21911293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective abolishment of pyrimidine nucleoside kinase activity of herpes simplex virus type 1 thymidine kinase by mutation of alanine-167 to tyrosine.
    Degrève B; Esnouf R; De Clercq E; Balzarini J
    Mol Pharmacol; 2000 Dec; 58(6):1326-32. PubMed ID: 11093770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testing the sensitivities of noncognate inhibitors to varicella zoster virus thymidine kinase: implications for postherpetic neuralgia therapy with existing agents.
    Yang L; Mo X; Yang H; Dai H; Tan F
    J Mol Model; 2014 Jul; 20(7):2321. PubMed ID: 24961898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular uptake of thymidine and antiherpetic drugs for thymidine kinase-deficient mutants of herpes simplex virus type 1.
    Bae PK; Kim JH; Kim HS; Chung IK; Paik SG; Lee CK
    Antiviral Res; 2006 Jul; 70(3):93-104. PubMed ID: 16546268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineering of a single conserved amino acid residue of herpes simplex virus type 1 thymidine kinase allows a predominant shift from pyrimidine to purine nucleoside phosphorylation.
    Balzarini J; Liekens S; Solaroli N; El Omari K; Stammers DK; Karlsson A
    J Biol Chem; 2006 Jul; 281(28):19273-9. PubMed ID: 16702226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Epstein-Barr virus thymidine kinase does not phosphorylate ganciclovir or acyclovir and demonstrates a narrow substrate specificity compared to the herpes simplex virus type 1 thymidine kinase.
    Gustafson EA; Chillemi AC; Sage DR; Fingeroth JD
    Antimicrob Agents Chemother; 1998 Nov; 42(11):2923-31. PubMed ID: 9797227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of scopadulciol-related molecules for their stimulatory effect on the cytotoxicity of acyclovir and ganciclovir against Herpes simplex virus type 1 thymidine kinase gene-transfected HeLa cells.
    Hayashi K; Rahman SM; Ohno H; Tanaka T; Toyooka N; Nemoto H; Hayashi T
    Chem Pharm Bull (Tokyo); 2004 Aug; 52(8):1015-7. PubMed ID: 15305006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and anti-HSV activity of tricyclic penciclovir and hydroxybutylguanine derivatives.
    Mohammed AF; Andrei G; Hayallah AM; Abdel-Moty SG; Snoeck R; Simons C
    Bioorg Med Chem; 2019 Mar; 27(6):1023-1033. PubMed ID: 30738653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation of Gln125 to Asn selectively abolishes the thymidylate kinase activity of herpes simplex virus type 1 thymidine kinase.
    Degrève B; Esnouf R; De Clercq E; Balzarini J
    Mol Pharmacol; 2001 Feb; 59(2):285-93. PubMed ID: 11160865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antiviral activity of 3-substituted derivatives of 3,9-dihydro-9-oxo-5H-imidazo[1,2-a]purines, tricyclic analogues of acyclovir and ganciclovir.
    Boryski J; Golankiewicz B; De Clercq E
    J Med Chem; 1991 Aug; 34(8):2380-3. PubMed ID: 1652016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of herpes simplex viruses selected in culture for resistance to penciclovir or acyclovir.
    Sarisky RT; Quail MR; Clark PE; Nguyen TT; Halsey WS; Wittrock RJ; O'Leary Bartus J; Van Horn MM; Sathe GM; Van Horn S; Kelly MD; Bacon TH; Leary JJ
    J Virol; 2001 Feb; 75(4):1761-9. PubMed ID: 11160674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and fluorescent properties of 6-(4-biphenylyl)-3,9-dihydro-9-oxo-5H-imidazo[1,2-a]purine analogues of acyclovir and ganciclovir.
    Goslinski T; Wenska G; Golankiewicz B; Balzarini J; De Clercq E
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):911-4. PubMed ID: 14565309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.